Qualitätssicherung
Um die Qualität der Analysen dauerhaft sicherzustellen, nimmt unser Labor regelmäßig an nationalen und internationalen Qualitätssicherungsprogrammen teil.
Jahr | Name des Ringversuchs | Organisation |
---|---|---|
Mai 2019 | ATP7B | RfB |
Mai 2019 | ApoE | RfB |
Mai 2019 | ApoB100 | RfB |
Mai 2019 | Aldolase B | RfB |
Mai 2019 | HFE (Hereditary Haemochromatosis) | RfB |
Mai 2019 | LCT (lactose intolerance) | RfB |
Mai 2019 | SERPINA1 | RfB |
Mai 2019 | MTHFR (Homocystinuria) | RfB |
Mai 2019 | Prothrombin 20210 | RfB |
Mai 2019 | Faktor V (Leiden) | RfB |
Mai 2019 | CYP2D6 | RfB |
Mai 2019 | HLA B27 | RfB |
Nov 2018 | CFTR | INSTAND |
Nov 2018 | BRCA1 / BRCA2 | INSTAND |
Nov 2018 | GJB2 | INSTAND |
Nov 2018 | MLH1/MSH2 | INSTAND |
Nov 2018 | Dystrophin | INSTAND |
Nov 2018 | HTT | INSTAND |
Nov 2018 | SMN1 | INSTAND |
Nov 2018 | CYP21A2 | INSTAND |
Okt 2018 | ApoE | RfB |
Okt 2018 | ApoB100 | RfB |
Okt 2018 | Aldolase B | RfB |
Okt 2018 | HFE (Hereditary Haemochromatosis) | RfB |
Okt 2018 | LCT (lactose intolerance) | RfB |
Okt 2018 | SERPINA1 | RfB |
Okt 2018 | MTHFR (Homocystinuria) | RfB |
Okt 2018 | Prothrombin 20210 | RfB |
Okt 2018 | Faktor V (Leiden) | RfB |
Okt 2018 | HLA B27 | RfB |
Okt 2018 | DPD Exon 14 skipping | RfB |
Okt 2018 | Classification of variants (trial) | GenQA |
Aug 2018 | Classification of BRCA1 and BRCA2 variants | EMQN/GenQA |
Jul 2018 | HRF (Hereditary Recurrent Fevers) | EMQN |
Apr 2018 | Faktor V (Leiden) | RfB |
Apr 2018 | Prothrombin 20210 | RfB |
Apr 2018 | MTHFR (Homocystinuria) | RfB |
Apr 2018 | SERPINA1 | RfB |
Apr 2018 | ApoE | RfB |
Apr 2018 | ApoB100 | RfB |
Apr 2018 | Aldolase B | RfB |
Apr 2018 | HFE (Hereditary Haemochromatosis) | RfB |
Apr 2018 | LCT (lactose intolerance) | RfB |
Apr 2018 | ATP7B (Morbus Wilson) | RfB |
Apr 2018 | HLA B27 | RfB |
Apr 2018 | CYP2D6 | RfB |
Nov 2017 | Classification of BRCA1 and BRCA2 variants | UK NEQAS |
Okt 2017 | Faktor V (Leiden) | RfB |
Okt 2017 | Prothrombin 20210 | RfB |
Okt 2017 | MTHFR (Homocystinuria) | RfB |
Okt 2017 | SERPINA1 | RfB |
Okt 2017 | ApoE | RfB |
Okt 2017 | ApoB100 | RfB |
Okt 2017 | Aldolase B | RfB |
Okt 2017 | HFE (Hereditary Haemochromatosis) | RfB |
Okt 2017 | LCT (lactose intolerance) | RfB |
Okt 2017 | HLA B27 | RfB |
Okt 2017 | CYP2D6 | RfB |
Okt 2017 | CYP21A2 | INSTAND |
Okt 2017 | CFTR | INSTAND |
Okt 2017 | BRCA1 / BRCA2 | INSTAND |
Okt 2017 | GJB2 | INSTAND |
Okt 2017 | MLH1/MSH2 | INSTAND |
Okt 2017 | Dystrophin | INSTAND |
Okt 2017 | HTT | INSTAND |
Okt 2017 | SMN1 | INSTAND |
Mai 2017 | ABCA4 | Probenaustausch |
Mai 2017 | RS1 | Probenaustausch |
Mai 2017 | PRPH2 | Probenaustausch |
Mai 2017 | Faktor V (Leiden) | RfB |
Mai 2017 | Prothrombin 20210 | RfB |
Mai 2017 | HFE (Hereditary Haemochromatosis) | RfB |
Mai 2017 | ApoB100 | RfB |
Mai 2017 | ApoE | RfB |
Mai 2017 | SERPINA1 | RfB |
Mai 2017 | LCT (lactose intolerance) | RfB |
Mai 2017 | HLA B27 | RfB |
Mai 2017 | CYP2D6 | RfB |
Mai 2017 | MTHFR (Homocystinuria) | RfB |
Mai 2017 | Aldolase B | RfB |
Mai 2017 | ATP7B (Morbus Wilson) | RfB |
Dez 2016 | TP53 | INSTAND |
Nov 2016 | Faktor V (Leiden) | INSTAND |
Nov 2016 | Prothrombin 20210 | INSTAND |
Sep 2016 | HFE (Hereditary Haemochromatosis) | INSTAND |
Sep 2016 | ApoB100 | INSTAND |
Sep 2016 | ApoE | INSTAND |
Sep 2016 | SERPINA1 | INSTAND |
Sep 2016 | LCT (lactose intolerance) | INSTAND |
Sep 2016 | HLA B27 | INSTAND |
Sep 2016 | CYP2D6 | INSTAND |
Sep 2016 | Hb S (sickle cell haemoglobin) | INSTAND |
Sep 2016 | DPD (5-fluorouracil toxicity) | INSTAND |
Sep 2016 | PRNP (prionopathy) | INSTAND |
Sep 2016 | GJB2 (Connexin 26) | INSTAND |
Sep 2016 | MSH2 / MLH1 (HNPCC) | INSTAND |
Sep 2016 | HTT (Huntington Disease) | INSTAND |
Sep 2016 | SMN1 (Spinal muscular atrophy) | INSTAND |
2016 | FH (Familial autosomal dominant hypercholesterolemia) | EMQN |
2016 | FRDA (Friedreich Ataxia) | EMQN |
2016 | MONODIAB (Monogenic Diabetes) | EMQN |
2016 | SHOX (Familial SHOX-related disorders) | EMQN |
2016 | Wilson Disease | EMQN |
Mai 2016 | Faktor V (Leiden) | INSTAND |
Mai 2016 | Prothrombin 20210 | INSTAND |
Mai 2016 | HFE (Hereditary Haemochromatosis) | INSTAND |
Mai 2016 | ApoB100 | INSTAND |
Mai 2016 | ApoE | INSTAND |
Mai 2016 | SERPINA1 | INSTAND |
Mai 2016 | LCT (lactose intolerance) | INSTAND |
Mai 2016 | HLA B27 | INSTAND |
Mai 2016 | HLA DQA1 *05/ DQB1*02 / DQB1*03:02 | INSTAND |
Mai 2016 | CYP21B | INSTAND |
Mai 2016 | CYP2D6 | INSTAND |
Mai 2016 | Hb S (sickle cell haemoglobin) | INSTAND |
Mai 2016 | DPD (5-fluorouracil toxicity) | INSTAND |
Mai 2016 | PRNP (prionopathy) | INSTAND |
Mai 2016 | CFTR | INSTAND |
Mai 2016 | BRCA1 / BRCA2 | INSTAND |
Mai 2016 | Dystrophin (Duchenne / Becker Muscular Dystrophy) | INSTAND |
2015 | Faktor V (Leiden) | INSTAND |
2015 | Prothrombin 20210 | INSTAND |
2015 | HFE (Hereditary Haemochromatosis) | INSTAND |
2015 | ApoB100 | INSTAND |
2015 | ApoE | INSTAND |
2015 | LCT (lactose intolerance) | INSTAND |
2015 | HLA B27 | INSTAND |
2015 | HLA DQA1 *05/ DQB1*02 / DQB1*03:02 | INSTAND |
2015 | CYP2D6 | INSTAND |
2015 | Hb S (sickle cell haemoglobin) | INSTAND |
2015 | DPD (5-fluorouracil toxicity) | INSTAND |
2015 | PRNP (prionopathy) | INSTAND |
2015 | Dystrophin (Duchenne / Becker Muscular Dystrophy) | INSTAND |
2015 | GJB2 (Connexin 26) | INSTAND |
2015 | HTT (Huntington Disease) | INSTAND |
2015 | SMN1 (Spinal muscular atrophy) | INSTAND |
2015 | Cystic fibrosis | CF network |
2015 | APKD (Autosomal Dominant Polycystic Kidney disease) | EMQN |
2015 | BRCA (Full sheme) | EMQN |
2015 | CAH (Congenital Adrenal hyperplasia) | EMQN |
2015 | HNPCC (Lynch syndrome) | EMQN |
2015 | MONODIAB (Monogenic Diabetes) | EMQN |
2015 | OI (Osteogenesis Imperfecta) | EMQN |
2015 | Wilson Disease | EMQN |
2015 | Faktor V (Leiden) | RfB |
2015 | a1-Proteinase-Inhibitor | RfB |
2015 | Aldolase B | RfB |
2015 | Faktor II | RfB |
2015 | ApoE | RfB |
2015 | HFE (Hereditary Haemochromatosis) | RfB |
2015 | MTHFR (Homocystinuria) | RfB |
2015 | ApoB100 | RfB |
2015 | HLA-B27 | RfB |
2015 | CYP2D6 | RfB |
2014 | MONODIAB (Monogenic Diabetes) | EMQN |
2014 | SMA (Spinal muscular atrophy) | EMQN |
2014 | HFE (Hereditary Haemochromatosis) | EMQN |
2014 | BRCA (Full scheme) | EMQN |
2014 | DFNB1 (Hereditary Deafness) | EMQN |
2014 | DMD (Duchenne / Becker Muscular Dystrophy) | EMQN |
2014 | HD (Huntington Disease) | EMQN |
2014 | HNPCC (Lynch Syndrome) | EMQN |
2012 | HFE (Hereditary Haemochromatosis) | EMQN |
2012 | DMD (Duchenne / Becker Muscular Dystrophy) | EMQN |
2012 | HNPCC (Lynch syndrome) | EMQN |
2012 | HD (Huntington Disease) | EMQN |
2012 | BRCA (Full scheme) | EMQN |
2012 | DFNB1 (Hereditary Deafness) | EMQN |
2012 | SMA (Spinal Muscular Atrophy) | EMQN |
2011 | FAP (Familial adenomatous polyposis) | EMQN |
2011 | MEN2 (Multiple Endocrine Neoplasia Type 2) | EMQN |
2011 | PKU (Phenylketonuria ) | EMQN |
2011 | SMA (Spinal Muscular Atrophy) | EMQN |
2010 | BRCA (Full sheme) | EMQN |
2010 | HNPCC (Lynch syndrome) | EMQN |
2010 | CMT (Charcot-Marie-Tooth disease) | EMQN |
2010 | VHL (Von Hippel Lindau Syndrome) | EMQN |